METHOHEXITAL (cas 18652-93-2)☆
-
Add time:09/10/2019 Source:sciencedirect.com
Methohexital is a rapidly-acting inducing agent for anesthesia, but currently has limited clinically usefulness except in a few particular situations. It is highly lipid soluble and its short duration of action is due to redistribution to leaner tissues and ultimately fat stores.
We also recommend Trading Suppliers and Manufacturers of METHOHEXITAL (cas 18652-93-2). Pls Click Website Link as below: cas 18652-93-2 suppliers
Prev:Clinical studySuperselective METHOHEXITAL (cas 18652-93-2) challenge prior to intracranial endovascular embolization☆
Next:Case ReportPositive pharmacologic provocative testing with METHOHEXITAL (cas 18652-93-2) during cerebral arteriovenous malformation embolization) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Seizures during intracarotid METHOHEXITAL (cas 18652-93-2) and amobarbital testing10/01/2019
- Short communicationLanguage assessment in Wada test: Comparison of METHOHEXITAL (cas 18652-93-2) and amobarbital09/27/2019
- Comparison of METHOHEXITAL (cas 18652-93-2) and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders09/26/2019
- Original ContributionEvaluation of METHOHEXITAL (cas 18652-93-2) as an alternative to propofol in a high volume outpatient pediatric sedation service09/25/2019
- Case ReportPositive pharmacologic provocative testing with METHOHEXITAL (cas 18652-93-2) during cerebral arteriovenous malformation embolization09/24/2019
- Clinical studySuperselective METHOHEXITAL (cas 18652-93-2) challenge prior to intracranial endovascular embolization☆09/09/2019
